Menu Back toWelcome-to-Day-Two

DIA/FDA Oligonucleotide-Based Therapeutics Conference


Welcome to Day Two

Session Chair(s)

Arthur A. Levin, PhD

Arthur A. Levin, PhD

  • Executive Vice President, Research and Development
  • Avidity Biosciences , United States
Welcome to Day Two